| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 552 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, [...], M Shahwan, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 528 | 2023 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 517 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 514 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 484 | 2024 |
| Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review G Muteeb, MT Rehman, M Shahwan, M Aatif Pharmaceuticals 16 (11), 1615, 2023 | 403 | 2023 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 379 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 319 | 2024 |
| Mutations in PYCR1 cause cutis laxa with progeroid features B Reversade, N Escande-Beillard, A Dimopoulou, B Fischer, SC Chng, ... Nature genetics 41 (9), 1016-1021, 2009 | 280 | 2009 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 225 | 2024 |
| Role of polyphenols in combating Type 2 Diabetes and insulin resistance M Shahwan, F Alhumaydhi, GM Ashraf, PMZ Hasan, A Shamsi International journal of biological macromolecules 206, 567-579, 2022 | 166 | 2022 |
| Patients’ beliefs towards generic medicines in The United Arab Emirates I Guella, N Hassan, M Shahwan, YM Al-Worafi, S Alkhoujah Research Journal of Pharmacy and Technology 14 (6), 3343-3346, 2021 | 155 | 2021 |
| Knowledge, attitude and practice of antibiotic use among university students: a cross sectional study in UAE A Jairoun, N Hassan, A Ali, O Jairoun, M Shahwan BMC public health 19, 1-8, 2019 | 138 | 2019 |
| Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes MJ Shahwan, AA Jairoun, A Farajallah, S Shanabli Diabetes & Metabolic Syndrome: Clinical Research & Reviews 13 (4), 2387-2392, 2019 | 127 | 2019 |
| Effect of khat, its constituents and restraint stress on free radical metabolism of rats TM Al-Qirim, M Shahwan, KR Zaidi, Q Uddin, N Banu Journal of ethnopharmacology 83 (3), 245-250, 2002 | 108 | 2002 |
| Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 VL Feigin, MD Abate, YH Abate, S Abd ElHafeez, F Abd-Allah, ... The Lancet Neurology 23 (10), 973-1003, 2024 | 100 | 2024 |
| Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 NV Bhattacharjee, AE Schumacher, A Aali, YH Abate, R Abbasgholizadeh, ... The lancet 403 (10440), 2057-2099, 2024 | 95 | 2024 |
| Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future B Godman, A Egwuenu, E Wesangula, N Schellack, AC Kalungia, ... Expert Opinion on Drug Safety 21 (8), 1089-1111, 2022 | 86 | 2022 |
| Spectroscopic, calorimetric and molecular docking insight into the interaction of Alzheimer’s drug donepezil with human transferrin: Implications of Alzheimer’s drug A Shamsi, M Al Shahwan, S Ahamad, MI Hassan, F Ahmad, A Islam Journal of Biomolecular Structure and Dynamics 38 (4), 1094-1102, 2020 | 75 | 2020 |
| Understanding the binding between Rosmarinic acid and serum albumin: In vitro and in silico insight A Shamsi, A Ahmed, MS Khan, M Al Shahwan, FM Husain, B Bano Journal of Molecular Liquids 311, 113348, 2020 | 73 | 2020 |
Anas ShamsiResearch Assistant Professor, Ajman University, UAE.Email yang diverifikasi di ajman.ac.ae
